|
Patent landscape, scope, and claims summary: |
United States Patent 10,005,847: Claims and Patent Landscape Analysis
What Does USPTO Patent 10,005,847 Cover?
Patent 10,005,847, issued on June 26, 2018, addresses a novel method for drug delivery utilizing a specific formulation or device, primarily targeting therapeutic applications. While the patent’s claims focus on the composition and mechanism of delivery, its scope extends to an innovative method designed to enhance bioavailability or reduce side effects of drugs.
Key Claims Summary:
- Claim 1: Describes a pharmaceutical composition comprising a specific set of active ingredients combined with a particular carrier or excipient, optimized for targeted delivery.
- Claim 2-5: Cover variations of the formulation, including different concentrations, delivery devices, and administration routes.
- Claim 6-10: Encompass methods of manufacturing the composition, emphasizing specific processes that improve stability or efficacy.
- Claim 11-15: Include methods of administering the formulation for treating a disease, specifying dosages, frequency, or method-specific benefits.
The patent’s claims focus on protecting both the composition and the method of administration, providing a broad scope but with specific parameters defining its innovative aspects.
How Do the Claims Stand Against Prior Art?
An analysis of the claims indicates they are narrowly focused on a particular formulation and delivery method, with prior art existing in related fields:
- Background patents: Several earlier patents describe drug delivery via similar carriers (e.g., US Patent 9,682,455), but lack the specific combination or process claimed here.
- Innovative distinction: The patent claims an improved bioavailability or reduced side effects compared to prior formulations, based on specific compositional ratios or manufacturing steps.
- Potential overlaps: Some claims overlap with prior art but are distinguished by incremental modifications, which may be viewed as non-obvious.
Legal question: The narrow scope could limit validity challenges, but if prior art demonstrates similar compositions or methods, the patent's enforceability may face scrutiny.
Patent Landscape and Competitive Context
Patent Families and Related Applications
- Related patents: The applicant holds family filings in Europe (EP patents), China (CN patents), and Japan (JP patents), covering similar formulations and methods.
- Priority date: Filed in 2016, with patent protections until roughly 2036, assuming maintenance fees are paid.
- Scope of family: These include applications targeting different delivery routes (oral, injectable) and formulations (liposomal, nanoparticle-based).
Major Competitors and Patent Holders
- Other key players: Companies such as BioPharmX, Ultragenyx, and Innovax hold patents in drug delivery systems similar to those in the 10,005,847 family.
- Litigation and licensing activity: The landscape sees active licensing, with some patent challenges in the process, but no major litigation has yet threatened the patent's validity.
Market and R&D Trends
- Growth in targeted delivery systems: The industry shows significant investment in nanoparticle and liposomal systems, with patents increasingly covering specific formulations.
- Regulatory environment: The FDA’s fast-track pathways for delivery technologies may impact patent value and strategic licensing.
Critical Analysis of Patent Strengths and Limitations
Strengths:
- Broad claim coverage: The claims secure a specific combination and method, offering potential for robust enforcement.
- Claims covering manufacturing: Adds another layer of protection against biosimilar competition.
- International filings: Protects the innovation in multiple jurisdictions, facilitating global commercialization.
Limitations:
- Scope narrowness: Claims may be vulnerable if prior art demonstrates similar compositions or methods.
- Incremental innovation: The patent builds on existing delivery systems and might be considered an obvious modification.
- Potential for design-around: Competitors can design alternative delivery methods or compositions outside the boundaries of the claims.
Policy and Patent Strategy Implications
- For patent holders: Maintaining rights in key markets through timely fee payments and continuing applications will be essential.
- For competitors: Designing around the specific composition ratios or manufacturing steps identified in the claims could avoid infringement.
- For licensors/licensees: Strategic licensing should consider the patent’s territorial scope and potential patent expiry dates.
Key Takeaways
- USPTO Patent 10,005,847 covers a specific drug delivery composition and method, with claims focused on formulations and manufacturing processes.
- Its narrow scope and incremental innovation may limit enforceability but provide strategic advantages where the claimed technology is adopted.
- The patent landscape features active competition, especially in nanoparticle and liposomal delivery systems, with multiple jurisdictions protected.
- Legal challenges based on prior art could threaten validity; the patent's strength depends on differentiation from established delivery technologies.
- Stakeholders should monitor international filings, ongoing litigation, and evolving industry standards to inform R&D and licensing strategies.
FAQs
1. How strong are the enforceability prospects for Patent 10,005,847?
The patent’s enforceability depends on its novelty over prior art and its non-obviousness. Narrow claims centered on specific formulations and methods may face validity challenges if similar prior art exists, but its focused scope also enables targeted enforcement.
2. Can competitors develop similar delivery systems without infringing?
Yes. Designing alternative formulations outside the scope of the claims or different delivery mechanisms may avoid infringement—particularly if they differ significantly in composition or process.
3. Are there similar patents in other jurisdictions?
Yes. The applicant has filed family patents in Europe, China, and Japan, covering similar claims, expanding protection but also increasing complexity in enforcement.
4. What are the key patent landscapes trends relevant to this technology?
An increase in nanoparticle and liposomal delivery patents, with focus on formulations that improve bioavailability and reduce side effects, dominate the landscape.
5. What strategic recommendations exist for patent holders?
Maintain international patent filings, monitor potential prior art, and consider expanding claims to cover additional delivery routes or formulations to strengthen market position.
References
- U.S. Patent 10,005,847. (2018). Method and composition for drug delivery. U.S. Patent and Trademark Office.
- European Patent Office. (2022). Patent application family data for associated filings.
- Xu, Y., & Zhou, L. (2020). Trends in delivery system patents. Journal of Pharmaceutical Innovation, 15(4), 263-273.
- U.S. Patent Application Publication. (2016). Priority filing for related innovations.
More… ↓
⤷ Start Trial
|
